Description
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) belonging to the family of short regulatory peptides studied in bioregulation research. It has been characterized in preclinical research as a putative modulator of gene expression in connective tissue, making it a useful tool compound for isolating peptide-bioregulation endpoints in experimental designs.
Cartalax has been examined in preclinical in vitro and rodent model studies of cartilage and connective-tissue cell activity, transcriptional regulation, and cellular aging endpoints. Its minimal tripeptide structure supports mechanistic characterization of short-peptide bioregulation in cell-based research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.